| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months (pa) | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | The manager follows a disciplined, process-driven, and thematic strategy focused on five core investment strategies: 1) Growth stocks that are really value stocks; 2) Traditional deep value; 3) The life sciences; 4) Miners and drillers expanding production into supply deficits; 5) Global special situations; The manager uses a macro overlay to manage exposure, hedging in three ways: 1) Direct shorts 2) Upside exposure to the VIX index 3) Index optionality |
| Manager Comments | The Frazis Fund rose +11.4% in January, outperforming AFM's Global Equity Benchmark by +7.67% and taking 12-month performance to +27.22%. The software firms the Fund was buying heavily late in 2019 rebounded strongly, with Afterpay moving to new highs. The Fund also saw strong performance from ASX-listed life sciences companies such as PolyNovo and Avita which are discussed in more depth in the latest report. Frazis noted, given the strong start to the year, there's an inclination to trim and realise profits, however they're going to stick to their long-term investment philosophy. So far the Fund's investment theses are on track during reporting season. |
| More Information |
